302 related articles for article (PubMed ID: 10178869)
1. Revisions to the general safety requirements for biological products--FD. Direct final rule.
Fed Regist; 1998 Apr; 63(75):19399-403. PubMed ID: 10178869
[TBL] [Abstract][Full Text] [Related]
2. Revisions to the general safety requirements for biological products; companion document to direct final rule--FDA. Proposed rule.
Fed Regist; 1998 Apr; 63(75):19431-4. PubMed ID: 10178870
[TBL] [Abstract][Full Text] [Related]
3. Amendment to examination and investigation sample requirements--FDA. Direct final rule.
Fed Regist; 1998 Sep; 63(186):51297-9. PubMed ID: 10185810
[TBL] [Abstract][Full Text] [Related]
4. Medical devices; humanitarian use of devices--FDA. Direct final rule.
Fed Regist; 1998 Apr; 63(74):19185-90. PubMed ID: 10178430
[TBL] [Abstract][Full Text] [Related]
5. Medical devices; 30-day notices and 135-day PMA (premarket approval application) supplement review--FDA. Direct final rule.
Fed Regist; 1998 Apr; 63(80 Pt 1):20530-3. PubMed ID: 10179319
[TBL] [Abstract][Full Text] [Related]
6. Medical device reporting: manufacturer reporting, importer reporting, user facility reporting, and distributor reporting--FDA. Direct final rule.
Fed Regist; 1998 May; 63(91):26069-77. PubMed ID: 10179334
[TBL] [Abstract][Full Text] [Related]
7. Medical devices; establishment registration and device listing for manufacturers and distributors of devices--FDA. Direct final rule.
Fed Regist; 1998 Sep; 63(188):51825-7. PubMed ID: 10185812
[TBL] [Abstract][Full Text] [Related]
8. Medical devices; reports of corrections and removals--FDA. Direct final rule.
Fed Regist; 1998 Aug; 63(152):42229-33. PubMed ID: 10181725
[TBL] [Abstract][Full Text] [Related]
9. Investigational new drug applications; clinical holds--FDA. Direct final rule.
Fed Regist; 1998 Dec; 63(239):68676-8. PubMed ID: 10187558
[TBL] [Abstract][Full Text] [Related]
10. Medical devices; medical device reporting; baseline reports. Direct final rule.
Food and Drug Administration, HHS
Fed Regist; 2008 Jun; 73(115):33692-5. PubMed ID: 18677824
[TBL] [Abstract][Full Text] [Related]
11. Current good manufacturing practice regulation and investigational new drugs. Direct final rule.
Food and Drug Administration. HHS
Fed Regist; 2006 Jan; 71(10):2458-62. PubMed ID: 16479693
[TBL] [Abstract][Full Text] [Related]
12. Revisions to the requirements applicable to blood, blood components and source plasma. Direct final rule.
Food and Drug Administration, HHS
Fed Regist; 2007 Aug; 72(158):45883-88. PubMed ID: 17847577
[TBL] [Abstract][Full Text] [Related]
13. General administrative rulings and decisions; amendment to the examination and investigation sample requirements; companion document to direct final rule--FDA. Proposed rule.
Fed Regist; 1998 Sep; 63(186):51322-4. PubMed ID: 10185811
[TBL] [Abstract][Full Text] [Related]
14. Amendment to the current good manufacturing practice regulations for finished pharmaceuticals. Direct final rule.
Food and Drug Administration, HHS
Fed Regist; 2007 Dec; 72(232):68064-70. PubMed ID: 18064770
[TBL] [Abstract][Full Text] [Related]
15. Revision of the requirements for live vaccine processing. Direct final rule.
Food and Drug Administration, HHS
Fed Regist; 2007 Oct; 72(201):59000-3. PubMed ID: 17966559
[TBL] [Abstract][Full Text] [Related]
16. Amendment of various device regulations to reflect current American Society for Testing and Material citations. Food and Drug Administration, HHS. Direct final rule.
Fed Regist; 2000 Jan; 65(15):3584-5. PubMed ID: 11010654
[TBL] [Abstract][Full Text] [Related]
17. Skin protectant drug products for over-the-counter human use; astringent drug products; final monograph; direct final rule. Direct final rule.
Food and Drug Administration, HHS
Fed Regist; 2003 Jun; 68(114):35290-3. PubMed ID: 12807133
[TBL] [Abstract][Full Text] [Related]
18. Amendments to general regulations of the Food and Drug Administration. Direct final rule.
Food and Drug Administration, HHS
Fed Regist; 2010 Nov; 75(229):73951-5. PubMed ID: 21121182
[TBL] [Abstract][Full Text] [Related]
19. Medical devices; pediatric uses of devices; requirement for submission of information on pediatric subpopulations that suffer from a disease or condition that a device is intended to treat, diagnose, or cure; direct final rule. Direct final rule.
Food and Drug Administration, HHS
Fed Regist; 2010 Apr; 75(62):16347-51. PubMed ID: 20383921
[TBL] [Abstract][Full Text] [Related]
20. Removal of regulations regarding certification of drugs composed wholly or partly of insulin--FDA. Direct final rule.
Fed Regist; 1998 May; 63(92):26694-9. PubMed ID: 10179341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
